These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 11561486)

  • 41. First International "Institute of Myology Workshop" on Facioscapulohumeral Muscular Dystrophy, Paris, May 22, 2007.
    Leterrier F; Voit T
    Neuromuscul Disord; 2008 Jun; 18(6):514-8. PubMed ID: 18541427
    [No Abstract]   [Full Text] [Related]  

  • 42. Differential diagnosis of scapuloperoneal syndrome.
    Milanov I; Ishpekova B
    Electromyogr Clin Neurophysiol; 1997 Mar; 37(2):73-8. PubMed ID: 9098670
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [The possible place of autologus cell therapy in facioscapulohumeral muscular dystrophy].
    Desnuelle C; Sacconi S; Marolleau JP; Larghero J; Vilquin JT
    Bull Acad Natl Med; 2005 Apr; 189(4):697-713; discussion 713-4. PubMed ID: 16245686
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Muscle involvement in the cerebro-oculo-facio-skeletal syndrome.
    Longman C; Sewry CA; Muntoni F
    Pediatr Neurol; 2004 Feb; 30(2):125-8. PubMed ID: 14984906
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [A patient with dermatomyositis and systemic sclerosis with preferential facioscapulohumeral muscle involvement and fatal cardiomyopathy].
    Oya Y; Toyama J; Ogawa M; Nonaka I; Kawai M
    Rinsho Shinkeigaku; 2001 Jun; 41(6):289-95. PubMed ID: 11771157
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Facioscapulohumeral muscular dystrophy - twelve cases from two pedigrees].
    An R; Xu Y
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2014 Jun; 31(3):402-3. PubMed ID: 24928028
    [No Abstract]   [Full Text] [Related]  

  • 47. Bent spine syndrome in facioscapulohumeral muscular dystrophy.
    Papadopoulos C; Papadimas GK; Spengos K; Manta P
    Muscle Nerve; 2011 Apr; 43(4):615; author reply 615-6. PubMed ID: 21404293
    [No Abstract]   [Full Text] [Related]  

  • 48. Scapuloperoneal muscular dystrophy is an independent variant of FSHD?
    Kazakov V; Rudenko D; Skorometz A; Kolynin V
    Acta Myol; 2009 Dec; 28(3):103. PubMed ID: 20476670
    [No Abstract]   [Full Text] [Related]  

  • 49. [An ambiguous pedigree of facioscapulohumeral muscular dystrophy which showed double EcoRI/BlnI resistant short fragments].
    Matsumura T; Etoh M; Goto K; Saito T; Nozaki S; Fujimura H; Shinno S
    Rinsho Shinkeigaku; 2002 Apr; 42(4):313-6. PubMed ID: 12561087
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Mobility assessment of patients with facioscapulohumeral dystrophy.
    Iosa M; Mazzà C; Frusciante R; Zok M; Aprile I; Ricci E; Cappozzo A
    Clin Biomech (Bristol, Avon); 2007 Dec; 22(10):1074-82. PubMed ID: 17850940
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Facioscapulohumeral dystrophy presenting as infantile facial diplegia and late-onset limb-girdle myopathy in members of the same family.
    Felice KJ; Jones JM; Conway SR
    Muscle Nerve; 2005 Sep; 32(3):368-72. PubMed ID: 15880682
    [TBL] [Abstract][Full Text] [Related]  

  • 52. RAGE-NF-kappaB pathway activation in response to oxidative stress in facioscapulohumeral muscular dystrophy.
    Macaione V; Aguennouz M; Rodolico C; Mazzeo A; Patti A; Cannistraci E; Colantone L; Di Giorgio RM; De Luca G; Vita G
    Acta Neurol Scand; 2007 Feb; 115(2):115-21. PubMed ID: 17212615
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Concurrence of facioscapulohumeral muscular dystrophy and myasthenia gravis.
    Sansone V; Saperstein DS; Barohn RJ; Meola G
    Muscle Nerve; 2004 Nov; 30(5):679-80. PubMed ID: 15389657
    [No Abstract]   [Full Text] [Related]  

  • 54. Clinical and histopathological heterogeneity in patients with 4q35 facioscapulohumeral muscular dystrophy (FSHD).
    Wood-Allum C; Brennan P; Hewitt M; Lowe J; Tyfield L; Wills A
    Neuropathol Appl Neurobiol; 2004 Apr; 30(2):188-91. PubMed ID: 15043716
    [No Abstract]   [Full Text] [Related]  

  • 55. No effect of folic acid and methionine supplementation on D4Z4 methylation in patients with facioscapulohumeral muscular dystrophy.
    van der Kooi EL; de Greef JC; Wohlgemuth M; Frants RR; van Asseldonk RJ; Blom HJ; van Engelen BG; van der Maarel SM; Padberg GW
    Neuromuscul Disord; 2006 Nov; 16(11):766-9. PubMed ID: 17005397
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Progress in researches on the molecular genetics of facioscapulohumeral muscular dystrophy].
    Su Q; Zhang C
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2001 Oct; 18(5):398-401. PubMed ID: 11592052
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Application of the Bgl II-Bln I dosage test to gene diagnosis of facioscapulohumeral muscular dystrophy 1A gene].
    Su QX; Zhang C; Xie YM; Zeng Y; Liu XR; Lu XL; Zhu YZ
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2004 Jun; 21(3):245-7. PubMed ID: 15192827
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Quantitative MR imaging of individual muscle involvement in facioscapulohumeral muscular dystrophy.
    Kan HE; Scheenen TW; Wohlgemuth M; Klomp DW; van Loosbroek-Wagenmans I; Padberg GW; Heerschap A
    Neuromuscul Disord; 2009 May; 19(5):357-62. PubMed ID: 19329315
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Vascular tortuosity and Coats'-like retinal changes in facioscapulohumeral muscular dystrophy.
    Tekin NF; Saatci AO; Kavukçu S
    Ophthalmic Surg Lasers; 2000; 31(1):82-3. PubMed ID: 10976570
    [No Abstract]   [Full Text] [Related]  

  • 60. Acupuncture Improves the Facial Muscular Function in a Case of Facioscapulohumeral Muscular Dystrophy.
    Liu Y; Xiao F; Liang X
    J Acupunct Meridian Stud; 2019 Apr; 12(2):73-76. PubMed ID: 30508665
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.